| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/20/2005 | CN1642913A Piperidine or 8-aza-bicyclo[3.2.1]oct-3-yl derivatives useful as modulators of chemokine receptor activity (especially CCR5) |
| 07/20/2005 | CN1642912A Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642911A Phthalimido derivatives as inhibitors of monoamine oxidase B |
| 07/20/2005 | CN1642910A Synthesis of indole thiazole compounds as ligands for the AH receptor |
| 07/20/2005 | CN1642907A Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642580A Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
| 07/20/2005 | CN1642577A Preparation comprising buprenorphine |
| 07/20/2005 | CN1642574A Remedies for glomerular diseases |
| 07/20/2005 | CN1642572A Remedy for glioblastoma |
| 07/20/2005 | CN1642569A Treatment of type I diabetes |
| 07/20/2005 | CN1642568A Methods and compositions for treating gastrointestinal toxicity induced by cytoablative therapy |
| 07/20/2005 | CN1642560A Hyaluronic acid mediated adenoviral transduction |
| 07/20/2005 | CN1642559A Combination comprising an HMG-CoA reductase inhibitor and an insulin secretor enhancer or an insulin sensitizer |
| 07/20/2005 | CN1642557A Combination of an aldosterone receptor antagonist and nicotinic acid or a nicotinic acid derivative |
| 07/20/2005 | CN1642555A Statin therapy for enhancing cognitive maintenance |
| 07/20/2005 | CN1642552A 4-(N-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors |
| 07/20/2005 | CN1642551A Inhibitors of histone deacetylase |
| 07/20/2005 | CN1642550A Beta-sheet mimetics and composition and methods relating thereto |
| 07/20/2005 | CN1642549A Pharmaceutical compositions comprising 2-(4-ethoxy-phenyl)-3-(4-methanesulfonyl-phenyl)-pyrazolo'1, 5-bipyridazine in nanoparticulate form |
| 07/20/2005 | CN1642547A Pharmaceutical composition and method for treating disorders of the central nervous system |
| 07/20/2005 | CN1642546A Solid preparation containing single crystal form |
| 07/20/2005 | CN1642545A Time-resolved fluorescence assay for the detection of multimeric forms ofA-beta(beta) or other aggregating polypeptides |
| 07/20/2005 | CN1642541A Method for treating cognitive disorders |
| 07/20/2005 | CN1640463A Anti-fatigue drink |
| 07/20/2005 | CN1640455A Temperature-reducing refreshing aerosol |
| 07/20/2005 | CN1640443A Rhizome gastrodiae preparation and its preparing method |
| 07/20/2005 | CN1640418A Anti-heat stroke Chinese medicine |
| 07/20/2005 | CN1211486C A DNA molecule encoding mutant prepro-neuropeptide Y, a mutant signal peptide, and uses thereof |
| 07/20/2005 | CN1211402C Novel use of mouse leukocyte interleukin-17 receptor sample protein |
| 07/20/2005 | CN1211401C Human leukocyte interleukin-17 receptor sample protein, and coding gene and use thereof |
| 07/20/2005 | CN1211382C Quinazoline ditosylate salt compounds |
| 07/20/2005 | CN1211381C Substituted imidazoles useful in treatment of inflammatory diseases |
| 07/20/2005 | CN1211375C Thiazole-derivatives |
| 07/20/2005 | CN1211374C Heterocyclic derivative, its preparation method and medicine compositioncontaining them |
| 07/20/2005 | CN1211373C 2,d-di (hetero-) arylamino (-oxy)-5-substituted pyrimidines as antineoplastic agents |
| 07/20/2005 | CN1211370C Biphenylsulfonyl-substd. imidazole derivs., their preparation process, their use as drug or diagnostic agent |
| 07/20/2005 | CN1211367C Prostaglandin agonists and their use to treat bone disorders |
| 07/20/2005 | CN1211365C Novel salt of perindopril and pharmacetuical composition contg. same |
| 07/20/2005 | CN1211362C New benzothiophene, benzofuran and indole compounds, process for their preparation and pharmaceutical compounds containing them |
| 07/20/2005 | CN1211353C Unsaturated hydroximic acid derivatives as PARP inhibitors |
| 07/20/2005 | CN1211107C Mixture for improving blood circulation |
| 07/20/2005 | CN1211091C Polyallylamine polymers for treating hypercholesterolemia |
| 07/20/2005 | CN1211090C Preparation of polyacrylicate sodium hemostatic for treating arterovenous hemorrhage |
| 07/20/2005 | CN1211089C Application of uridine phosphorylase inhibitor and composition containing the same |
| 07/20/2005 | CN1211085C Compositions having improved stability |
| 07/20/2005 | CN1211077C Histamine H2 antagonist effervescent composition |
| 07/20/2005 | CN1211063C Compositions comprising organosiloxane resins for delivering oral care substances |
| 07/19/2005 | US6919470 Aryl and heteroaryl sulfonates |
| 07/19/2005 | US6919461 Anticancer agents; antiarthritic agents |
| 07/19/2005 | US6919455 4-((9-((3-Cyclopentyloxy-4-methoxy)benzyl)-6,8 dimethylpurin)-2-yl-3-oxypropyl)pyridine N-oxide chemical intermediate; phosphodiesterase inhibitors; antiasthmatic and antiinflammatory agents; chronic obstructive pulmonary disease |
| 07/19/2005 | US6919432 Substances and their uses |
| 07/19/2005 | US6919425 Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery |
| 07/19/2005 | US6919378 Pharmaceutical solutions of modafinil compounds |
| 07/19/2005 | US6919377 Cyclohexylamine derivative as subtype selective NMDA receptor antagonists |
| 07/19/2005 | US6919370 Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof |
| 07/19/2005 | US6919367 Substituted thioacetamides |
| 07/19/2005 | US6919362 For use as hypoglycaemic and hypolipidaemic agents |
| 07/19/2005 | US6919357 Human sexual disorders; therapy for impotency |
| 07/19/2005 | US6919355 Amide derivatives as NMDA receptor antagonists |
| 07/19/2005 | US6919354 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 07/19/2005 | US6919353 Enzyme inhibitors of phosphordiesterase 4 having minimal side effects; antiinflammatory agents; antiallergens; asthma; neurodegenerative disorders; antidiabetic agents; pain; anti-tumor, -carcinogenic and -arthritic agents |
| 07/19/2005 | US6919351 Aza-and polyaza-naphthalenyl-carboxamides useful as HIV integrase inhibitors |
| 07/19/2005 | US6919350 Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds |
| 07/19/2005 | US6919349 Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient |
| 07/19/2005 | US6919347 Antidiabetic agents; antiinflammatory agents; analgesics; antiallergens |
| 07/19/2005 | US6919344 Heterocyclic amines such as N-(Pyridin-4-yl)-(1-(4-fluoro-benzyl)indol-3-yl)glyoxylamide, used for prophylaxis of skin disorders, rheumatic diseases or arthritis |
| 07/19/2005 | US6919340 Kinase moderators; controlling gene expression; immunosuppressants; autoimmune disease; rheumatic disorders; skin disorders; antitumor agents; anticancer agents |
| 07/19/2005 | US6919339 ABCA-1 elevating compounds |
| 07/19/2005 | US6919338 Antiproliferative agents; anticancer agents |
| 07/19/2005 | US6919335 Heterocycles that are inhibitors of IMPDH enzyme |
| 07/19/2005 | US6919324 Functionalized stilbene derivatives as improved vascular targeting agents |
| 07/19/2005 | US6919322 Phenyl Phosphonate Fructose-1,6-Bisphosphatase Inhibitors |
| 07/19/2005 | US6919317 For therapy of diseases involving fungal or suspected fungal infection, for immunomodulation or immunosuppression in conditions in which fungal or suspected fungal colonisation of e.g.skin plays a role |
| 07/19/2005 | US6919307 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 07/19/2005 | US6919208 Methods and compositions for enhancing the delivery of a nucleic acid to a cell |
| 07/19/2005 | US6919075 Bacteriophage displaying aβ epitopes and method of use |
| 07/19/2005 | US6919072 Comprises matrix metalloproteinase (MMP) inhibitor; for promoting collagen production |
| 07/19/2005 | CA2071248C Composition containing dioxabicyclo-[3.3.0]octane derivative |
| 07/14/2005 | WO2005064008A1 Method and compositions for identifying anti-hiv therapeutic compounds |
| 07/14/2005 | WO2005063788A1 Benzimidazole derivatives and medical uses thereof |
| 07/14/2005 | WO2005063738A1 Novel 2-heteroaryl-substituted benzimidazole derivative |
| 07/14/2005 | WO2005063725A1 Phenylpropanoic acid derivatives |
| 07/14/2005 | WO2005063720A1 Amide derivative and medicine |
| 07/14/2005 | WO2005063705A1 Benzene compounds disubstituted with cyclic groups at the 1- and 2-positions |
| 07/14/2005 | WO2005063704A1 Azetidine ring compounds and drugs comprising the same |
| 07/14/2005 | WO2005063294A1 Inhibitor for the formation of ϝ-secretase complex |
| 07/14/2005 | WO2005063241A1 Preventive and/or therapeutic agent for disease in which mitochondrial benzodiazepine receptor participates |
| 07/14/2005 | WO2005062828A2 New compounds useful as metal chelators |
| 07/14/2005 | WO2005062748A2 Bicyclic carbohydrate compounds useful in the treatment of infections caused by herpesviridae |
| 07/14/2005 | WO2005046612A3 Hydroxy piperidine derivatives to treat gaucher disease |
| 07/14/2005 | WO2005009480A3 Implants containing codrugs |
| 07/14/2005 | WO2004017923A3 Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix |
| 07/14/2005 | WO2003059294A3 Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor |
| 07/14/2005 | WO2003029424A3 Novel proteins and nucleic acids encoding same |
| 07/14/2005 | US20050155089 Transport protein for use in identifying modulators for prevention and treatment of inflammation, cardiovascular, neurological, reproductive and developmental disorders |
| 07/14/2005 | US20050154230 Urea derivatives |
| 07/14/2005 | US20050154215 Extraction from Zanthoxylum naranjillo leaves; nuclear magnetic resonance; for treatment of Chaga's disease |
| 07/14/2005 | US20050154202 Substituted aryl amides |
| 07/14/2005 | US20050154190 compounds obtained by the screening of the present invention are useful as agents for the prevention/treatment of, for example, neurodegenerative diseases, immunological diseases, edema, acid indigestion, etc. |
| 07/14/2005 | US20050154061 peroxisome-proliferator-activated receptor (PPAR)-delta agonist; 2-[4-[[[2-[(2,4-Dichlorophenyl)amino]-2-oxoethyl]cyclohexylamino]methyl]-2-methylphenoxy]-2-methylpropanoic acid; cardiovascular disorders, dyslipidaemias or restenosis; improves HDL/LDL cholesterol ratio; side effect reduction |